Celsius vs. Colgate-Palmolive: Which Stock Should Investors Consider Before the Start of 2027?

Investors evaluating Celsius (CELH) versus Colgate-Palmolive (CL) face a decision between explosive growth potential and steady dividends. Celsius targets the rapidly expanding functional energy drink market, while Colgate-Palmolive is a global leader in oral and personal care products. Both represent contrasting strategies within the consumer goods sector.

Celsius leverages a distribution partnership with PepsiCo to access extensive retail networks. However, this concentration on one key distributor poses considerable risk, accounting for nearly 43.2% of its total net revenue in 2025. The company also relies on independent distributors and e-commerce channels such as Amazon and Shopify. Despite a 85.5% revenue increase to $2.5 billion in FY 2025, net income fell to $108 million due to high expansion costs and integration of acquired brands.

Colgate-Palmolive, in contrast, offers stability through its recurring revenue model. Its largest customer, Walmart, accounts for about 11% of total net sales in the latest report. The company generated $20.4 billion in revenue, with net income at $2.1 billion, reflecting consistent growth. However, Colgate faces challenges from macroeconomic factors, geopolitical risks, and intense competition in the consumer staples market.

While Celsius may appear more attractive initially due to its valuation, Colgate-Palmolive stands out as a Dividend King, having raised its dividend for 63 consecutive years. Despite recent stock price declines, Colgate's shares have risen by 22% over the past year, outperforming both Celsius and the S&P 500's 14.3% return. For investors seeking defensiveness and reliable income, Colgate-Palmolive's steady performance and consistent dividend payouts make it the preferable choice in uncertain market conditions.